Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,marketState,shortName,market,exchangeDataDelayedBy,exchange,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,HSKA,281426000.0,10424900,1186000,,306000,,1871000,23111000,25470000,1173000,1173000,,-920000,,,,-1565000,60503000,59330000,35033000,-867000,,1871000,1871000,53879000.0,562008000.0,144300000.0,425273000.0,9546000.0,569573000.0,104000.0,4441000.0,-145625000.0,18432000.0,89968000.0,8786000.0,56494000.0,238455000.0,37786000.0,16758000.0,8786000.0,39952000.0,322762000.0,6518000.0,36024000.0,84287000.0,39357000.0,14958000.0,153000,-13131000,-106000,164355000,-5870000,165357000,152121000,-679000,-440000,1337000,3571000,-9000000,-1818000,858000,-217000,2550000,-262000,284976000.0,en-US,US,EQUITY,True,Delayed Quote,USD,1620304200,1620304200,1620304200,-0.793,0.98,-0.05,-5404.4,40.821,256.896,13.324005,0.051865365,210.75182,59.468185,0.28217164,2817016576,275.73468,6.6196322,15,America/New_York,EDT,-14400000,2,1.8545095,263.41 - 270.22,265.3,0.0,0.0,10,8,finmb_29433,PRE,Heska Corporation,us_market,0,NCM,False,False,270.22,1630526403,4.9200134,266.7,270.22,263.41,42035,NasdaqCM,Heska Corporation,USD,62470,50600,176.95999,1.8974907,93.26 - 275.26,-5.0400085,-0.018309992,93.26,275.26,1349827200,1.68,,,275.26,93.26,256.9,210.75,62.47k,50.6k,10.42M,,9.02M,5.74%,98.55%,324.37k,5.23,4.46%,3.11%,317.6k,,,,,,0.00%,"Oct 09, 2012","Sep 25, 2012",1:10,"Dec 29, 2010","Dec 30, 2020","Mar 30, 2021",-3.19%,1.42%,0.44%,-2.14%,227.17M,24.88,97.40%,81.29M,15.11M,-7.24M,-0.79,,238.46M,22.87,90.33M,21.24,8.54,40.82,5.44M,11.83M,Value,80538,Healthcare,602,3,5,"Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Additionally, the company provides a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. It sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is based in Loveland, Colorado.",Loveland,970 493 7272,CO,4,1609372800,1622505600,3,United States,http://www.heska.com,86400,3,3760 Rocky Mountain Avenue,970 619 3003,Diagnostics & Research
t-1,HSKA,142785000.0,10424900,2751000,,1011000,,2465000,21023000,26574000,2800000,2800000,,-920000,,,,-1454000,64322000,61522000,37748000,-1789000,,2465000,2465000,55992000.0,423650000.0,112786000.0,287053000.0,10290000.0,399839000.0,95000.0,3955000.0,-150861000.0,17539000.0,88276000.0,14169000.0,36593000.0,86334000.0,42115000.0,5694000.0,14169000.0,40999000.0,171275000.0,6704000.0,37074000.0,49013000.0,40037000.0,15119000.0,2428000,-6554000,-1133000,265000,4729000,2223000,1826000,-825000,670000,7445000,1648000,-6650000,-1508000,-3942000,-217000,1412000,-200000,129160000.0,en-US,US,EQUITY,True,Delayed Quote,USD,1620304200,1620304200,1620304200,-0.793,0.98,-0.05,-5404.4,40.821,256.896,13.324005,0.051865365,210.75182,59.468185,0.28217164,2817016576,275.73468,6.6196322,15,America/New_York,EDT,-14400000,2,1.8545095,263.41 - 270.22,265.3,0.0,0.0,10,8,finmb_29433,PRE,Heska Corporation,us_market,0,NCM,False,False,270.22,1630526403,4.9200134,266.7,270.22,263.41,42035,NasdaqCM,Heska Corporation,USD,62470,50600,176.95999,1.8974907,93.26 - 275.26,-5.0400085,-0.018309992,93.26,275.26,1349827200,1.68,,,275.26,93.26,256.9,210.75,62.47k,50.6k,10.42M,,9.02M,5.74%,98.55%,324.37k,5.23,4.46%,3.11%,317.6k,,,,,,0.00%,"Oct 09, 2012","Sep 25, 2012",1:10,"Dec 29, 2010","Dec 30, 2020","Mar 30, 2021",-3.19%,1.42%,0.44%,-2.14%,227.17M,24.88,97.40%,81.29M,15.11M,-7.24M,-0.79,,238.46M,22.87,90.33M,21.24,8.54,40.82,5.44M,11.83M,Value,80538,Healthcare,602,3,5,"Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Additionally, the company provides a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. It sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is based in Loveland, Colorado.",Loveland,970 493 7272,CO,4,1609372800,1622505600,3,United States,http://www.heska.com,86400,3,3760 Rocky Mountain Avenue,970 619 3003,Diagnostics & Research
t-2,HSKA,134285000.0,10424900,2197000,,-1891000,-171000.0,-5219000,20228000,23404000,979000,979000,,-2339000,,,,3413000,56636000,55657000,33232000,-2870000,,-5304000,-5219000,55295000.0,420314000.0,109164000.0,274882000.0,7608000.0,383875000.0,95000.0,4548000.0,-153326000.0,19457000.0,85302000.0,7799000.0,29065000.0,84508000.0,33519000.0,5170000.0,7799000.0,40801000.0,166227000.0,7185000.0,33088000.0,51728000.0,39348000.0,12277000.0,2020000,-117000,14000,508000,-4079000,536000,5319000,-42000,-66000,4994000,3337000,-6650000,193000,-545000,-217000,7763000,-170000,132708000.0,en-US,US,EQUITY,True,Delayed Quote,USD,1620304200,1620304200,1620304200,-0.793,0.98,-0.05,-5404.4,40.821,256.896,13.324005,0.051865365,210.75182,59.468185,0.28217164,2817016576,275.73468,6.6196322,15,America/New_York,EDT,-14400000,2,1.8545095,263.41 - 270.22,265.3,0.0,0.0,10,8,finmb_29433,PRE,Heska Corporation,us_market,0,NCM,False,False,270.22,1630526403,4.9200134,266.7,270.22,263.41,42035,NasdaqCM,Heska Corporation,USD,62470,50600,176.95999,1.8974907,93.26 - 275.26,-5.0400085,-0.018309992,93.26,275.26,1349827200,1.68,,,275.26,93.26,256.9,210.75,62.47k,50.6k,10.42M,,9.02M,5.74%,98.55%,324.37k,5.23,4.46%,3.11%,317.6k,,,,,,0.00%,"Oct 09, 2012","Sep 25, 2012",1:10,"Dec 29, 2010","Dec 30, 2020","Mar 30, 2021",-3.19%,1.42%,0.44%,-2.14%,227.17M,24.88,97.40%,81.29M,15.11M,-7.24M,-0.79,,238.46M,22.87,90.33M,21.24,8.54,40.82,5.44M,11.83M,Value,80538,Healthcare,602,3,5,"Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Additionally, the company provides a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. It sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is based in Loveland, Colorado.",Loveland,970 493 7272,CO,4,1609372800,1622505600,3,United States,http://www.heska.com,86400,3,3760 Rocky Mountain Avenue,970 619 3003,Diagnostics & Research
t-3,HSKA,130524000.0,10424900,1696000,,-6686000,-89000.0,-6357000,17895000,17865000,-1726000,-1726000,,-2333000,,,,-212000,45712000,47438000,27847000,-4960000,,-6474000,-6357000,54782000.0,415687000.0,106941000.0,270047000.0,7316000.0,376899000.0,94000.0,3267000.0,-148107000.0,19391000.0,84741000.0,2373000.0,31868000.0,79189000.0,32854000.0,8205000.0,2373000.0,39861000.0,158382000.0,7265000.0,32077000.0,50037000.0,40772000.0,11891000.0,-5068000,-105296000,311000,1361000,-3201000,1178000,-112056000,-72000,213000,-8334000,3330000,-6650000,-1013000,-176000,-56000,2626000,-106000,125528000.0,en-US,US,EQUITY,True,Delayed Quote,USD,1620304200,1620304200,1620304200,-0.793,0.98,-0.05,-5404.4,40.821,256.896,13.324005,0.051865365,210.75182,59.468185,0.28217164,2817016576,275.73468,6.6196322,15,America/New_York,EDT,-14400000,2,1.8545095,263.41 - 270.22,265.3,0.0,0.0,10,8,finmb_29433,PRE,Heska Corporation,us_market,0,NCM,False,False,270.22,1630526403,4.9200134,266.7,270.22,263.41,42035,NasdaqCM,Heska Corporation,USD,62470,50600,176.95999,1.8974907,93.26 - 275.26,-5.0400085,-0.018309992,93.26,275.26,1349827200,1.68,,,275.26,93.26,256.9,210.75,62.47k,50.6k,10.42M,,9.02M,5.74%,98.55%,324.37k,5.23,4.46%,3.11%,317.6k,,,,,,0.00%,"Oct 09, 2012","Sep 25, 2012",1:10,"Dec 29, 2010","Dec 30, 2020","Mar 30, 2021",-3.19%,1.42%,0.44%,-2.14%,227.17M,24.88,97.40%,81.29M,15.11M,-7.24M,-0.79,,238.46M,22.87,90.33M,21.24,8.54,40.82,5.44M,11.83M,Value,80538,Healthcare,602,3,5,"Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. Additionally, the company provides a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. It sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is based in Loveland, Colorado.",Loveland,970 493 7272,CO,4,1609372800,1622505600,3,United States,http://www.heska.com,86400,3,3760 Rocky Mountain Avenue,970 619 3003,Diagnostics & Research
